Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET.
Makino I, Yamaguchi T, Sato N, Yasui T, Kita I.
World J Gastroenterol. 2009 Aug 7;15(29):3691-3.
Similar articles
Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET).
Koh T, Taniguchi H, Yamaguchi A, Kunishima S, Yamagishi H.
J Surg Oncol. 2003 Oct;84(2):74-81.
Distinguishing benign from malignant gallbladder wall thickening using FDG-PET.
Oe A, Kawabe J, Torii K, Kawamura E, Higashiyama S, Kotani J, Hayashi T, Kurooka H, Tsumoto C, Kubo S, Shiomi S.
Ann Nucl Med. 2006 Dec;20(10):699-703.
Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
Rehani B, Strohmeyer P, Jacobs M, Mantil J.
Clin Nucl Med. 2006 Dec;31(12):812-3.
Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on ¹⁸F-FDG PET: report of a case.
Sawada S, Shimada Y, Sekine S, Shibuya K, Yoshioka I, Matsui K, Okumura T, Yoshida T, Nagata T, Uotani H, Tsukada K.
Int Surg. 2013 Oct-Dec;98(4):372-8. doi: 10.9738/INTSURG-D-13-00092.1.
A case of xanthogranulomatous cholecystitis preoperatively diagnosed with contrast-enhanced ultrasonography.
Ueda J, Yoshida H, Arima Y, Mamada Y, Taniai N, Mineta S, Yoshioka M, Kawano Y, Naito Z, Uchida E.
J Nippon Med Sch. 2011;78(3):194-8.
Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis.
Rodríguez-Fernández A, Gómez-Río M, Llamas-Elvira JM, Ortega-Lozano S, Ferrón-Orihuela JA, Ramia-Angel JM, Mansilla-Roselló A, Martínez-del-Valle MD, Ramos-Font C.
Am J Surg. 2004 Aug;188(2):171-5.
[Xanthogranulomatous cholecystitis mimicking carcinoma of gallbladder].
Baykara M, Karahan OI.
Tani Girisim Radyol. 2004 Mar;10(1):56-8. Turkish.
Chronic cholecystitis with hilar bile duct stricture mimicking gallbladder carcinoma on positron emission tomography: A case report.
Ke QH, He ZL, Duan X, Zheng SS.
Mol Clin Oncol. 2013 May;1(3):517-520. Epub 2013 Mar 14.
Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
Hales NW, Krempl GA, Medina JE.
Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8. doi: 10.1016/j.amjoto.2007.04.006.
False positive diagnosis of metastatic esophageal carcinoma on positron emission tomography: a case report of cholecystitis simulating a hepatic lesion.
Hansen N, Brown RK, Khan A, Frey KA, Orringer M.
Clin Nucl Med. 2010 Jun;35(6):409-12. doi: 10.1097/RLU.0b013e3181db4cd2.
Is there any role of positron emission tomography computed tomography for predicting resectability of gallbladder cancer?
Kim J, Ryu JK, Kim C, Paeng JC, Kim YT.
J Korean Med Sci. 2014 May;29(5):680-4. doi: 10.3346/jkms.2014.29.5.680. Epub 2014 Apr 25.
Xanthogranulomatous cholecystitis mimicking stage IV gallbladder cancer.
Enomoto T, Todoroki T, Koike N, Kawamoto T, Matsumoto H.
Hepatogastroenterology. 2003 Sep-Oct;50(53):1255-8.
Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U, Even-Sapir E.
Semin Nucl Med. 2007 May;37(3):206-22.
18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.
Fluorodeoxyglucose positron emission tomography-computed tomography: a novel approach for the diagnosis of cholecystitis for equivocal diagnoses after ultrasound imaging.
Nasseri Y, Ourian AJ, Waxman A, D'Angolo A, Thomson LE, Margulies DR.
Am Surg. 2012 Oct;78(10):1109-13.
Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW, Yoon YH, Yoon YH, Kim SM, Koo BS.
Ann Surg Oncol. 2011 May;18(5):1306-11. doi: 10.1245/s10434-010-1469-2. Epub 2010 Dec 8.
Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.
Nuklearmedizin. 2014;53(3):89-94. doi: 10.3413/Nukmed-0605-13-06. Epub 2013 Nov 13.
[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.
Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.010. Chinese.
Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.
Acad Radiol. 2014 Jan;21(1):11-20. doi: 10.1016/j.acra.2013.09.015. Review.
Filters: Manage Filters